C07C61/06

FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST
20230219892 · 2023-07-13 ·

The present disclosure relates generally to various forms and compositions useful as beta adrenergic agonists and uses of the same in the treatment of diseases associated with an adrenergic receptor. In one aspect, the disclosure provides a crystalline solid form of Compound 1: selected from Form A and Form B and salt forms thereof.

##STR00001##

FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST
20230219892 · 2023-07-13 ·

The present disclosure relates generally to various forms and compositions useful as beta adrenergic agonists and uses of the same in the treatment of diseases associated with an adrenergic receptor. In one aspect, the disclosure provides a crystalline solid form of Compound 1: selected from Form A and Form B and salt forms thereof.

##STR00001##

Pharmaceutical co-crystal composition and use thereof
11685757 · 2023-06-27 · ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

Pharmaceutical co-crystal composition and use thereof
11685757 · 2023-06-27 · ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF
20210094979 · 2021-04-01 ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF
20210094979 · 2021-04-01 ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF
20190367547 · 2019-12-05 ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

PHARMACEUTICAL CO-CRYSTAL COMPOSITION AND USE THEREOF
20190367547 · 2019-12-05 ·

The current invention relates to series of co-crystals of platinum analogues and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

Pharmaceutical co-crystal composition and use thereof
10428099 · 2019-10-01 · ·

The current invention relates to series of co-crystals of platinum analogs and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.

Pharmaceutical co-crystal composition and use thereof
10428099 · 2019-10-01 · ·

The current invention relates to series of co-crystals of platinum analogs and their pharmaceutical use. The co-crystals of the subject invention may be used in the treatment or prevention of cancers and virus infections.